AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 156 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $39,655 | -28.2% | 28,529 | +2.7% | 0.00% | -100.0% |
| Q4 2022 | $55,262 | +2.3% | 27,770 | +4.2% | 0.00% | 0.0% |
| Q3 2022 | $54,000 | -35.7% | 26,638 | +1.2% | 0.00% | 0.0% |
| Q2 2022 | $84,000 | -22.9% | 26,312 | +0.3% | 0.00% | 0.0% |
| Q1 2022 | $109,000 | -12.8% | 26,245 | +0.5% | 0.00% | 0.0% |
| Q4 2021 | $125,000 | -11.3% | 26,115 | -0.8% | 0.00% | 0.0% |
| Q3 2021 | $141,000 | +5.2% | 26,332 | +1.0% | 0.00% | 0.0% |
| Q2 2021 | $134,000 | -28.7% | 26,084 | -6.6% | 0.00% | -50.0% |
| Q1 2021 | $188,000 | +48.0% | 27,934 | +0.5% | 0.00% | +100.0% |
| Q4 2020 | $127,000 | +13.4% | 27,803 | -3.8% | 0.00% | 0.0% |
| Q3 2020 | $112,000 | +19.1% | 28,892 | +46.9% | 0.00% | 0.0% |
| Q2 2020 | $94,000 | +6.8% | 19,673 | -21.9% | 0.00% | -50.0% |
| Q1 2020 | $88,000 | – | 25,185 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $102,442,000 | 9.84% |
| TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $77,176,000 | 1.36% |
| Sivik Global Healthcare LLC | 600,000 | $2,856,000 | 0.95% |
| THB ASSET MANAGEMENT | 651,150 | $3,099,000 | 0.90% |
| Eversept Partners, LP | 886,587 | $4,220,154 | 0.58% |
| Spark Investment Management LLC | 30,100 | $143,000 | 0.52% |
| GLOBEFLEX CAPITAL L P | 240,680 | $1,146,000 | 0.29% |
| Alambic Investment Management, L.P. | 19,493 | $93,000 | 0.23% |
| GSA CAPITAL PARTNERS LLP | 49,901 | $238,000 | 0.13% |
| C M BIDWELL & ASSOCIATES LTD | 29,550 | $141,000 | 0.13% |